Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | 10-K | biib-20171231x10k.htm | 10-K | 4142574 |
2 | EXHIBIT 10.10 | biib-20171231xex1010.htm | EX-10.10 | 27576 |
3 | EXHIBIT 10.11 | biib-20171231xex1011.htm | EX-10.11 | 27456 |
4 | EXHIBIT 10.28 | biib-20171231xex1028.htm | EX-10.28 | 16293 |
5 | EXHIBIT 10.31 | biib-20171231xex1031.htm | EX-10.31 | 74606 |
6 | EXHIBIT 10.32 | biib-20171231xex1032.htm | EX-10.32 | 39717 |
7 | EXHIBIT 10.33 | biib-20171231xex1033.htm | EX-10.33 | 321097 |
8 | EXHIBIT 21 | biib-20171231xex21.htm | EX-21 | 59453 |
9 | EXHIBIT 23 | biib-20171231xex23.htm | EX-23 | 2658 |
10 | EXHIBIT 31.1 | biib-20171231xex311.htm | EX-31.1 | 13956 |
11 | EXHIBIT 31.2 | biib-20171231xex312.htm | EX-31.2 | 14299 |
12 | EXHIBIT 32.1 | biib-20171231xex321.htm | EX-32.1 | 6575 |
19 | acquiredinprocessrdchart.jpg | GRAPHIC | 17454 | |
20 | amortofacqintanassetschart.jpg | GRAPHIC | 19882 | |
21 | anticd20revenueschart.jpg | GRAPHIC | 45295 | |
22 | avonex.jpg | GRAPHIC | 5670 | |
23 | benepalia02.jpg | GRAPHIC | 5283 | |
24 | biogenidec.jpg | GRAPHIC | 11141 | |
25 | biogenlogostandarda06.jpg | GRAPHIC | 95885 | |
26 | biosimilarschart.jpg | GRAPHIC | 20890 | |
27 | collabprofitsharechart.jpg | GRAPHIC | 18726 | |
28 | corporatestrategy.jpg | GRAPHIC | 37006 | |
29 | costofsaleschart.jpg | GRAPHIC | 32446 | |
30 | equityinlossofinvesteechart.jpg | GRAPHIC | 18186 | |
31 | fampyra.jpg | GRAPHIC | 2031 | |
32 | financialhighlightschart.jpg | GRAPHIC | 34559 | |
33 | flixabi.jpg | GRAPHIC | 5565 | |
34 | fumaderm.jpg | GRAPHIC | 3140 | |
35 | gazyva.jpg | GRAPHIC | 21759 | |
36 | geographicsaleschart.jpg | GRAPHIC | 34372 | |
37 | glonfvcontconsideration.jpg | GRAPHIC | 18937 | |
38 | incometaxprovisionchart.jpg | GRAPHIC | 35385 | |
39 | interferonchart.jpg | GRAPHIC | 36664 | |
40 | noncontrollinginterestchart.jpg | GRAPHIC | 19938 | |
41 | ocrevusmultiplesclerosislogo.jpg | GRAPHIC | 10027 | |
42 | oiechart.jpg | GRAPHIC | 20272 | |
43 | otherrevenueschart.jpg | GRAPHIC | 31270 | |
44 | part1researchanddevchart.jpg | GRAPHIC | 20758 | |
45 | plegridy.jpg | GRAPHIC | 5127 | |
46 | principalproductschart.jpg | GRAPHIC | 70489 | |
47 | rdpiechart2015.jpg | GRAPHIC | 35703 | |
48 | rdpiechart2016.jpg | GRAPHIC | 36799 | |
49 | rdpiechart2017.jpg | GRAPHIC | 37393 | |
50 | researchanddevelopmentchart.jpg | GRAPHIC | 70608 | |
51 | reserveschart.jpg | GRAPHIC | 33492 | |
52 | restructuringchargeschart.jpg | GRAPHIC | 19001 | |
53 | rituxan.jpg | GRAPHIC | 9985 | |
54 | sellinggeneraladminchart.jpg | GRAPHIC | 20779 | |
55 | spinrazachart.jpg | GRAPHIC | 24256 | |
56 | spinrazalogonewa01.jpg | GRAPHIC | 72059 | |
57 | stockperformancechart.jpg | GRAPHIC | 63262 | |
58 | tecfidera.jpg | GRAPHIC | 7384 | |
59 | tecfiderachart.jpg | GRAPHIC | 35340 | |
60 | teclitigationchart.jpg | GRAPHIC | 18080 | |
61 | tysabri.jpg | GRAPHIC | 6359 | |
62 | tysabrichart.jpg | GRAPHIC | 36944 | |
63 | zinbryta.jpg | GRAPHIC | 4850 | |
64 | zinbrytachart.jpg | GRAPHIC | 21065 | |
Complete submission text file | 0000875045-18-000005.txt | 22881028 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
13 | XBRL INSTANCE DOCUMENT | biib-20171231.xml | EX-101.INS | 4971313 |
14 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | biib-20171231.xsd | EX-101.SCH | 120700 |
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | biib-20171231_cal.xml | EX-101.CAL | 152081 |
16 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | biib-20171231_def.xml | EX-101.DEF | 677137 |
17 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | biib-20171231_lab.xml | EX-101.LAB | 1576222 |
18 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | biib-20171231_pre.xml | EX-101.PRE | 1020896 |
IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19311 | Film No.: 18567291
SIC: 2836 Biological Products, (No Diagnostic Substances)